Aug 2026
Tumor-tropic E. coli engineered as living T and NK cell engagers
Shao-Bo Yang, Anna Clara Bader, S. Sendker et al.
· bioRxiv · 0 citations
We have 2 of 2 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
In animal model, the ES302 showed significantly superior efficacy over monospecific therapies, markedly reducing disease activity, histopathological scoring, and pro-inflammatory cytokines, compatible with high-concentration formulation for subcutaneous administration.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.